Samuel Bardsley

Samuel Bardsley is a Global Product Leader for Tozorakimab at AstraZeneca, where they currently serve as Executive Director. With over 15 years in the pharmaceutical industry, Samuel has extensive experience in strategic direction and cross-functional team leadership, demonstrated through their previous role as Executive Director for Airsupra. They began their career at GSK, progressing from an intern to various managerial roles, showcasing their expertise in regulatory project management and corporate development. Samuel holds a Bachelor of Arts from the University of York and a Master of Science from Imperial College London.